Engineered imine reductase enables high-efficiency synthesis of S-nicotine, suggesting advancements for industrial applications.
An engineered imine reductase variant capable of synthesizing (S)-nicotine was developed through structure-guided directed evolution. Enzyme library screening identified IR-55 as an ideal parent, exhibiting high yield and good enantioselectivity. Targeted combinatorial mutagenesis of a crucial loop (residues 227-236) produced mutant M6 with 97.7% ee. By dynamically regulating the pH within the range of 7.5-8.0, a substrate loading of 250 g/L was achieved, resulting in a conversion rate of 94% after 4 h with space-time yield (STY) of 58.7 g/L/h. Scale-up with 2.5 g of substrate in 20 mL for 6 h yielded 1.23 g of product (97.2% ee, 75.9% isolated yield STY 10.3 g/L/h), demonstrating superior space-time yield and operational efficiency compared to existing biocatalytic routes. This work not only offers an efficient pathway for the industrial synthesis of (S)-nicotine through rational enzyme engineering but also provides a comprehensive strategy to overcome substrate inhibition and enzyme inactivation under high substrate concentration.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: